Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US Bill Seeks To Eliminate Biosimilar Interchangeability Trial Burden
‘Biosimilar Red Tape Elimination Act’ Would Remove Need For Switching Studies
Nov 25 2022
•
By
Dave Wallace
The bill is aimed at eliminating ‘red tape and unnecessary studies’ • Source: Shutterstock
More from Legislation
More from Pink Sheet